Mark Sheptoff Financial Planning Has Trimmed By $407,011 Its Ford Mtr Co Del (F) Stake; Corbus Pharmaceuticals Holdings (CRBP) SI Increased By 19.28%

December 17, 2017 - By Dolores Ford

Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) had an increase of 19.28% in short interest. CRBP’s SI was 6.31M shares in December as released by FINRA. Its up 19.28% from 5.29M shares previously. With 1.34M avg volume, 5 days are for Corbus Pharmaceuticals Holdings (NASDAQ:CRBP)’s short sellers to cover CRBP’s short positions. The SI to Corbus Pharmaceuticals Holdings’s float is 16.69%. The stock decreased 2.05% or $0.15 during the last trading session, reaching $7.15. About 1.69 million shares traded or 136.16% up from the average. Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) has risen 152.94% since December 17, 2016 and is uptrending. It has outperformed by 136.24% the S&P500.

Mark Sheptoff Financial Planning Llc decreased Ford Mtr Co Del (F) stake by 72.69% reported in 2017Q2 SEC filing. Mark Sheptoff Financial Planning Llc sold 37,001 shares as Ford Mtr Co Del (F)’s stock declined 13.59%. The Mark Sheptoff Financial Planning Llc holds 13,900 shares with $156,000 value, down from 50,901 last quarter. Ford Mtr Co Del now has $49.97 billion valuation. The stock increased 0.96% or $0.12 during the last trading session, reaching $12.58. About 48.66M shares traded or 35.70% up from the average. Ford Motor Company (NYSE:F) has declined 16.63% since December 17, 2016 and is downtrending. It has underperformed by 33.33% the S&P500.

Among 4 analysts covering Corbus Pharma (NASDAQ:CRBP), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Corbus Pharma had 16 analyst reports since September 8, 2015 according to SRatingsIntel. Cantor Fitzgerald maintained the shares of CRBP in report on Monday, July 17 with “Buy” rating. Cantor Fitzgerald maintained the stock with “Buy” rating in Monday, November 6 report. On Tuesday, August 8 the stock rating was maintained by Noble Financial with “Buy”. As per Monday, March 7, the company rating was initiated by Aegis Capital. The rating was maintained by Cantor Fitzgerald on Tuesday, June 13 with “Buy”. JMP Securities initiated Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) on Tuesday, September 8 with “Mkt Outperform” rating. Cantor Fitzgerald initiated the shares of CRBP in report on Wednesday, October 5 with “Buy” rating. Cantor Fitzgerald maintained the stock with “Buy” rating in Thursday, October 19 report. Noble Financial maintained it with “Buy” rating and $19 target in Friday, November 11 report. The firm has “Overweight” rating given on Thursday, March 30 by Cantor Fitzgerald.

Corbus Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, focuses on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases. The company has market cap of $392.34 million. The Company’s lead product candidate includes JBT-101, a novel oral endocannabinoid-mimetic drug, which is in Phase 2 clinical trials for the treatment of systemic sclerosis, cystic fibrosis, diffuse cutaneous, skin-predominant dermatomyositis, and systemic lupus erythematosus diseases. It currently has negative earnings.

Among 26 analysts covering F&M Bank (NYSE:F), 9 have Buy rating, 3 Sell and 14 Hold. Therefore 35% are positive. F&M Bank had 55 analyst reports since August 7, 2015 according to SRatingsIntel. The company was maintained on Sunday, August 13 by RBC Capital Markets. Jefferies maintained Ford Motor Company (NYSE:F) on Friday, September 8 with “Hold” rating. The firm has “Buy” rating given on Monday, September 11 by Piper Jaffray. As per Tuesday, November 22, the company rating was initiated by Berenberg. The stock of Ford Motor Company (NYSE:F) has “Hold” rating given on Friday, February 10 by Jefferies. The stock has “Buy” rating by Standpoint Research on Wednesday, October 4. The rating was maintained by S&P Research with “Strong Buy” on Friday, September 25. The stock has “Buy” rating by Tigress Financial on Friday, March 31. The firm has “Buy” rating by Vetr given on Thursday, August 13. As per Friday, August 7, the company rating was initiated by Compass Point.

Analysts await Ford Motor Company (NYSE:F) to report earnings on January, 25. They expect $0.44 EPS, up 46.67% or $0.14 from last year’s $0.3 per share. F’s profit will be $1.75 billion for 7.15 P/E if the $0.44 EPS becomes a reality. After $0.43 actual EPS reported by Ford Motor Company for the previous quarter, Wall Street now forecasts 2.33% EPS growth.

Investors sentiment increased to 0.87 in Q2 2017. Its up 0.04, from 0.83 in 2017Q1. It is positive, as 90 investors sold F shares while 355 reduced holdings. 76 funds opened positions while 292 raised stakes. 2.11 billion shares or 2.60% less from 2.17 billion shares in 2017Q1 were reported. Pr Herzig invested 4.17% in Ford Motor Company (NYSE:F). Texas-based Fincl Pro has invested 0% in Ford Motor Company (NYSE:F). Private Fincl Bank Comm holds 0.02% or 16,110 shares. Vantage Ptnrs Ltd Llc has invested 0.05% of its portfolio in Ford Motor Company (NYSE:F). Maple Capital holds 0.05% or 15,526 shares in its portfolio. Grimes & Company Inc owns 171,698 shares. Deprince Race Zollo, Florida-based fund reported 2.84 million shares. Mutual Of Omaha Retail Bank Wealth Mgmt invested in 114,810 shares. Tocqueville Asset Management Ltd Partnership holds 2.06 million shares or 0.28% of its portfolio. Jacobs Levy Equity Management Inc has invested 0.52% of its portfolio in Ford Motor Company (NYSE:F). Wellington Shields Capital Management Limited Co has 0.2% invested in Ford Motor Company (NYSE:F). Norinchukin Bankshares The accumulated 472,634 shares or 0.11% of the stock. Alexandria Cap Ltd Liability Com reported 1,115 shares. Cna Fin owns 190,129 shares or 0.5% of their US portfolio. North Star Asset Mgmt has 35,860 shares.

Since August 2, 2017, it had 0 insider purchases, and 7 insider sales for $3.55 million activity. Armstrong Steven R. sold $273,080 worth of stock. 25,000 Ford Motor Company (NYSE:F) shares with value of $287,500 were sold by Thai-Tang Hau N. $453,600 worth of stock was sold by Hinrichs Joseph R on Tuesday, September 5. FARLEY JR JAMES D sold $285,000 worth of stock. The insider Lawler John T. sold $886,864. OJAKLI ZIAD S had sold 92,815 shares worth $1.06M.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: